title: Noninvasive evaluation of hepatic fibrosis in children with infant hepatitis syndrome.
abstract: OBJECTIVE
  To elucidate the impact of hemodynamic para-meters on ultrasonography and serum fibrosis markers for the assessment of liver fibrosis in the children with infant hepatitis syndrome (IHS).
  
  
  METHODS
  Forty-one children with IHS and 46 healthy infants were examined by ultrasonography, and several hemodynamic indices such as peak systolic velocity (PSV) and resistant index (RI) of proper hepatic artery (PHA) were measured. Serum fibrosis markers including hyaluronic acid (HA), pre-collagen type-III (PC-III), collagen type IV (C-IV), and laminin (LN) were assayed by radioimmunoassays. In children with IHS, liver tissues were obtained either by ultrasound-guided liver biopsy (n = 35) or in the course of operation (n = 6). The stages of hepatic fibrosis were scored as mild (S1 and S2), moderate (S3), or severe (S4) according to liver histological diagnosis. Multiple groups comparative and Spearman correlative analyses were carried out.
  
  
  RESULTS
  Histopathologically, 39 children (95.1%) were found to have hepatic fibrosis, 12 of them stage S1 or S2, 12 stage S3, and 15 stage S4. PSV, RI of the PHA, and serum HA showed a consecutive increase from mild to severe hepatic fibrosis and a close positive correlation with hepatic fibrosis in IHS group (r = 0.717, 0.745 and 0.712, respectively, P = 0.001). The Doppler waveform of HV was also positively correlated with the degree of hepatic fibrosis in IHS group (r = 0.783, P < 0.001).
  
  
  CONCLUSIONS
  Combination of ultrasonic studies on the hepatic hemodynamics with the evaluation of serum HA may provide an indicator for hepatic fibrosis in patients with IHS. This may be a useful noninvasive method for the diagnosis and evaluation of the prognosis of IHS.
authors.affiliation: Department of Ultrasound, First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China. gxydlzx@163.com
authors.forename: Zhi-Xian
authors.initials: ZX
authors.lastname: Li
authors.forename: Yun
authors.initials: Y
authors.lastname: He
authors.forename: Ji
authors.initials: J
authors.lastname: Wu
authors.forename: Dan-Mei
authors.initials: DM
authors.lastname: Liang
authors.forename: Bu-Lin
authors.initials: BL
authors.lastname: Zhang
authors.forename: Hong
authors.initials: H
authors.lastname: Yang
authors.forename: Ling-Ling
authors.initials: LL
authors.lastname: Wang
authors.forename: Yun
authors.initials: Y
authors.lastname: Ma
authors.forename: Kang-Lai
authors.initials: KL
authors.lastname: Wei
mesh_terms: D015415:Biomarkers; D001706:Biopsy; D005260:Female; D006505:Hepatitis / Q000150:complications*; D006801:Humans; D007223:Infant; D008099:Liver / Q000098:blood supply / Q000000981:diagnostic imaging* / Q000473:pathology; D008103:Liver Cirrhosis / Q000097:blood / Q000175:diagnosis* / Q000000981:diagnostic imaging; D008297:Male; D011446:Prospective Studies; D013577:Syndrome; D018615:Ultrasonography, Doppler, Color; D018617:Ultrasonography, Doppler, Pulsed
chemical_list: D015415:Biomarkers